The Multiple Sclerosis Journal (MSJ) – the sole official journal of ECTRIMS – is a peer-reviewed international journal that focuses on multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system.
Read through our select ECTRIMS 2024 publications, made available for open access or free reading through the end of September
What has the scientific community learned following two years of COVID-19 in the MS community? This editorial highlights research showing the responses of the MS Community to close the gaps of knowledge that COVID-19 has brought to us”.
This ECTRIMS-endorsed publication outlines evidence presented during the 2021 international ECTRIMS Focused Workshop on the risk of infections for MS & neuromyelitis optica spectrum disorder DMTs.
We are delighted to announce that, after an extensive recruitment process, Jaume Sastre-Garriga has been appointed as the new Editor in Chief (EIC) of the MS Journal, effective 1 January 2025. Jaume has already spent many years working on the Journal as both the Controversies Editor and as one of the European Co-Editors, and brings with him a wealth of experience in the research of multiple sclerosis.
This appointment follows the decision by current EIC Alan Thompson to step down from the role after 18 years. Alan has been instrumental in the Journal’s success, and we are sure the whole community joins us in thanking him for his leadership and dedication. Alan will remain a member of the MS Journal Editorial Board.
The Journal is also currently searching for two editors to fill the roles of European & African Editor and Topical Reviews Editor to succeed Jaume and Ellen Mowry, who has decided to step down. Interested parties may contact Jaume and Ellen for more information, or follow up with the Journal Publisher Lizzie Brophy.
Impact of COVID-19 on Multiple Sclerosis Care and Management: Results from the European Committee for Treatment and Research in Multiple Sclerosis Survey
Journal topics include:
Key series:
Controversies in MS: a series of debates published regularly in the journal since October 2011. Read both sides of the debate on a wide range of key topics.
Topical reviews are amongst MSJ’s most downloaded articles, and are both succinct and up-to-date.
This journal is a member of the Committee on Publication Ethics (COPE). The President of ECTRIMS is co-editor of the Multiple Sclerosis Journal. For further information please visit http://msj.sagepub.com.